Swipe om te navigeren naar een ander artikel
To determine the frequency, characteristics and risk factors of cardiac device infections in the Isala Hospital.
We retrospectively studied all patients who underwent cardiac device procedures performed in the cardiac catheterisation lab and the operating room from 2010 to 2012. All patients who developed a cardiac device infection were reviewed for its characteristics.
31/2026 patients developed a cardiac device infection (1.5 %). One (3.2 %) patient died within 30 days of hospitalisation. Device infection rates for procedures in the catheterisation lab and operating room were similar (p = 0.60). Positive cultures were present in 27/31 (87 %) cases. These consisted predominantly of micro-organisms that are part of the skin flora (84 %). The mean time between device procedure and infection was 14 ± 21 months (range 0–79). Cardiac device infection was significantly associated with device revision, (65 % were revisions in patients with device infection vs. 30 % revisions in patients without device infection, p = 0.011) and placement of a left ventricular lead in pacemaker implantations (59 % of patients with vs. 51 % of patients without device infection, p < 0.001).
The frequency of cardiac device infection was 1.5 % with a mortality of 3.2 % within 30 days, which is lower compared with other registries. Cardiac device infections were associated with device revisions and placement of left ventricular leads in pacemaker implantations.
Gandhi T, Crawford T, Riddell J. Cardiovascular implantable electronic device associated infections. Infect Dis Clin N Am. 2012;26:57–76. CrossRef
European Heart Rhythm Association, Heart Rhythm Society, Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol. 2006;48:e247–e346. CrossRefPubMed
Atham E, Chum VH, Tattevin P, et al. Clinical Characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA. 2012;307:1727–35. CrossRef
Eggimann P, Waldvogel F. Pacemaker and defibrillator infections. In: Waldvogel FA, Bisno AL, editor. Infections associated with indwelling medical devices. Washington, DC: American Society for Microbiology Press; 2000. p. 247. CrossRef
ESC. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis. Eur Heart J. 2009;30:2369–413. CrossRef
- Characteristics of cardiac device infections in the Isala Hospital; a large volume tertiary care cardiology centre
H. C. F. Schram
J. J. J. Smit
P. P. H. M. Delnoy
A. R. Ramdat Misier
- Bohn Stafleu van Loghum